What is Strathspey Crown?
Strathspey Crown operates as a specialized growth equity firm with a distinct focus on the lifestyle healthcare landscape. The organization distinguishes itself by aligning with board-certified physician specialists across high-growth medical verticals, including plastic surgery, ophthalmology, dermatology, dentistry, and orthopedics. By bridging the gap between clinical practice and commercial innovation, Strathspey Crown facilitates the market entry of advanced services and technologies tailored to the self-pay consumer segment. This physician-led investment strategy ensures that the firm remains at the forefront of medical advancements while maintaining a robust portfolio of high-value healthcare assets.
How much funding has Strathspey Crown raised?
Strathspey Crown has raised a total of $45M across 6 funding rounds:
Private Equity
$18.1M
Private Equity
$22.8M
Unspecified
$2.4M
Private Equity
$1.1M
Debt
$150K
Debt
$378K
Private Equity (2012): $18.1M, investors not publicly disclosed
Private Equity (2013): $22.8M, investors not publicly disclosed
Unspecified (2015): $2.4M, investors not publicly disclosed
Private Equity (2015): $1.1M, investors not publicly disclosed
Debt (2020): $150K backed by PPP
Debt (2021): $378K with participation from PPP
Key Investors in Strathspey Crown
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed institutional partner contributing to the firm's long-term capital structure and strategic development.
Undisclosed Investor
A private equity participant focused on the lifestyle healthcare market, supporting the firm's mission to commercialize physician-led medical innovations.
What's next for Strathspey Crown?
Looking ahead, Strathspey Crown is positioned to capitalize on the increasing consumer demand for elective and self-pay medical procedures. The firm's recent capital allocation suggests a strategic pivot toward strengthening its existing portfolio companies and exploring new opportunities in medical technology integration. As the healthcare industry continues to shift toward patient-centric, elective care models, Strathspey Crown's ability to leverage its network of physician investors will be critical in maintaining its competitive advantage. Future growth initiatives will likely focus on scaling operational efficiencies across its subsidiaries and expanding its footprint in the rapidly evolving lifestyle medicine sector.
See full Strathspey Crown company page
